Cart summary

You have no items in your shopping cart.

Anticancer agent 136

SKU: orb2278422

Description

Compound 22 is a triazole-modified geldanamycin analog that binds Hsp90 with a Kd of 3.86 µM. It demonstrates cytotoxic activity with an IC50 of 3.38 µM in HDF cells, inducing apoptosis. This small molecule is a useful research tool for studying Hsp90 inhibition in cancer biology and apoptosis mechanisms in vitro.

Research Area

Cell Biology

Images & Validation

Key Properties

MW742.86
FormulaC40H50N6O8
TargetApoptosis

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Anticancer agent 136 (orb2278422)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%